Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06845631 · ClinicalTrials.gov registry record · NA

Retrospective-Prospective PNS Study

A NA study of Chronic Pain, sponsored by Curonix.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06845631 is a NA study of Chronic Pain that is actively recruiting participants, run by Curonix. The registered enrollment target is 40 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06845631, a NA study of Chronic Pain, is actively recruiting participants, sponsored by Curonix.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective-prospective study in which 40 patients have received a permanent Freedom PNS System. Subjects presented with chronic, intractable pain of peripheral nerve origin refractory to standard medical and/or surgical treatment. A retrospective chart review will be conducted to assess baseline and follow-up parameters in patients who have received a permanent implant with the Freedom PNS system for at least 12 months. Missing data might be collected after informed consent.

Conditions Studied

Interventions

  • DEVICE PNS device, observational study, no intervention during study

Study Locations (1)

Ohio

  • The Metrohealth System - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-07-01
Est. Completion 2026-12-01
Phase NA

Sponsor

Curonix

5 total trials

What the Registry Record Tells You About NCT06845631

The ClinicalTrials.gov registry entry for NCT06845631 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The listed sponsor is Curonix, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which PNS device, observational study, no intervention during study is the first listed.

NCT06845631 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06845631 about?

NCT06845631 is a clinical study titled "Retrospective-Prospective PNS Study". This is a retrospective-prospective study in which 40 patients have received a permanent Freedom PNS System. Subjects presented with chronic, intractable pain of peripheral nerve origin refractory to standard medical and/or surgical treatment. A retrospective chart review will be conducted to asses...

What is the current status of trial NCT06845631?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-07-01. Estimated completion is 2026-12-01.

What conditions does trial NCT06845631 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06845631?

The interventions under investigation include: PNS device, observational study, no intervention during study (DEVICE).

Who is sponsoring clinical trial NCT06845631?

This trial is sponsored by Curonix, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06845631 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.